Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Nektar Therapeutics | StockGist | StockGist

Companies
NKTR
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings NKTRSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Nektar Therapeutics

Filed Jan 30, 2026

Accepted Jan 29, 2026, 7:00 PM ET

CIK 0000906709

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

NEKTAR THERAPEUTICS

Person Type

IA

CUSIP: 640268306

Recent Filings

Nektar Therapeutics1 weeks ago

Nektar Therapeutics3 weeks ago

Nektar Therapeutics3 weeks ago

Nektar Therapeutics1 months ago

Nektar Therapeutics1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice